Hirotsu Bio Science

Tokyo, Japan · Founded 2016 · Privately Held (backing)

Developer of a cancer detection technology designed to identify small amounts of cancerous odors in urine with high accuracy. Hirotsu Bio Science is based in Tokyo, Japan and was founded in 2016. Its last reported valuation was $500 million in Jan 2025. It has raised $126 million.

Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$125.5M
Last round
—

Who backs Hirotsu Bio Science?

19 investors
InvestorType
SBI InvestmentVenture capital
Mitsui Sumitomo Insurance Co.Other
Shinkin CapitalGrowth equity
Aioi Nissay Dowa InsuranceOther
As One (Japan)—
Avex Digital—
Data Business Supply—
HibiShin Capital—
Ichinen Holdings—
Iyogin Capital—
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hirotsu Bio Science investors

19 investors are on record for Hirotsu Bio Science, including SBI Investment, Mitsui Sumitomo Insurance Co., Shinkin Capital and Aioi Nissay Dowa Insurance.

Free account
More of Hirotsu Bio Science with a free account
  • ·The complete investor list: 19 names
  • ·Watch Hirotsu Bio Science: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like Hirotsu Bio Science. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View